Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2005
09/29/2005WO2005089287A2 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
09/29/2005WO2005089266A2 Rapid methods for detecting methylation of a nucleic acid molecule
09/29/2005WO2005089264A2 Method of diagnosis of inclusion body myopathy - paget bone disease - frontotemporal dementia syndrome
09/29/2005WO2005089254A2 A method of evaluating freshness of a fish product
09/29/2005WO2005089156A2 Methods for the indentification of inhibitors of histidinol dehydrogenase as antibiotics
09/29/2005WO2005089122A2 Animals with reduced body fat and increased bone density
09/29/2005WO2005089080A2 Method and kit for screening, pharmaceutical compositions and method for treatment of autoimmune disorders
09/29/2005WO2005072456A3 Single use lyophilized enzymatic reagents, and kits and methods for using same
09/29/2005WO2005070104A3 REAL-TIME POLYMERASE CHAIN REACTION-BASED GENOTYPING ASSAY FOR β2-ADRENERGIC RECEPTOR SINGLE NUCLEODITE POLYMORPHISM
09/29/2005WO2005069980A3 Microfluidic chemostat and a method to prevent biofilm formation with same
09/29/2005WO2005067692A3 Detection and quantification of analytes in solution using polymers
09/29/2005WO2005063801A3 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof
09/29/2005WO2005062709A3 Integrated viral complexes, methods of production thereof, vaccines containing same and methods of use thereof
09/29/2005WO2005061002A3 Composition and methods for modulating cns activity
09/29/2005WO2005059165A3 Methods for detecting bacterial pathogens
09/29/2005WO2005056752A3 Methods and compositions for delivering polynucleotides
09/29/2005WO2005055813A3 Interaction of nmda receptor with the protein tyrosine phosphatase step in psychotic disorders
09/29/2005WO2005055804A3 Methods and compositions for diagnosing epithelial cell cancer
09/29/2005WO2005054513A3 Method to diagnose or screen for inflammatory diseases
09/29/2005WO2005052592A3 Methods for diagnosis, stratification, and monitoring of alzheimer’s disease
09/29/2005WO2005051985A3 Methods for purifying pertussis toxin and peptides useful therefor
09/29/2005WO2005047864A3 Magnetic nanoparticles, magnetic detector arrays, and methods for their use in detecting biological molecules
09/29/2005WO2005046616A3 Viral propagation system and uses thereof
09/29/2005WO2005038005A9 Shc proteins as therapeutic targets in proliferative diseases
09/29/2005WO2005033336A3 Materials and methods relating to breast cancer diagnosis
09/29/2005WO2005029066A3 Diagnostic markers and pharmacological targets in heart failure and related reagents and methods of use thereof
09/29/2005WO2005026739A3 Increasing the bioavailability of carotenoids by enzymatic hydrolysis of the corresponding fatty acid esters
09/29/2005WO2005024011A3 Novel ubp8rp polypeptides and their use in the treatment of psoriasis
09/29/2005WO2005017204B1 Use single nucleotide polymorphsm in the coding region of the porcine leptin receptor gene to enhance pork production
09/29/2005WO2005012329A3 Kinase and phosphatase assays
09/29/2005WO2005004204A3 An electrochemical method and resulting structures for attaching molecular and biomolecular structures to semiconductor micro and nanostructures
09/29/2005WO2005003336A3 Newly identified cholinephosphotransferases and ethanolaminephosphotransferases
09/29/2005WO2004108939A8 Bav packaging regions and e1 transcriptional control regions
09/29/2005WO2004092338A3 Compositions, splice variants and methods relating to cancer specific genes and proteins
09/29/2005WO2004092331A3 Composition and method for nucleic acid sequencing
09/29/2005WO2004089302A3 Posh polypeptides, complexes and related methods
09/29/2005WO2004085618A3 Method of screening for target ligands
09/29/2005WO2004076632A3 Methods of screening for trpm5 modulators
09/29/2005WO2004073609A3 Posh associated kinases and related methods
09/29/2005WO2004063355A3 Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer
09/29/2005WO2004050682A3 Phosphospecific pak antibodies and diagnostic kits
09/29/2005WO2004037991A3 Prkcb1 as modifier of branching morphogenesis and methods of use
09/29/2005WO2004031365A3 Sulfatases and methods of use thereof
09/29/2005WO2004014314A3 Methods and compositions concerning poxviruses and cancer
09/29/2005WO2002079491A3 Method for correlating gene expression profiles with protein expression profiles
09/29/2005US20050216979 Rose plant named 'poulcs012'
09/29/2005US20050216970 Corn event MIR604
09/29/2005US20050216969 Insect resistant cotton seed: transformation events of cotton plants with one or more polynucleotide sequences inserted into specific site(s) within the genome of a cotton cell
09/29/2005US20050216965 Using concentration of cytochrome p450 in swine liver as diagnostic indicator of off flavored meat; increasing the metabolism of skatole in pig and enhancing meat flavor
09/29/2005US20050216964 Using swine organs devoid of porcine endogenous retrovirus (PERV) for xenotransplantation and treatment of end-stage organ diseases
09/29/2005US20050216961 Cancer associated protein kinases and their uses
09/29/2005US20050216960 Using tumor necrosis factor related apoptosis inducing ligand receptor (TRAIL-R) to identify modulators of dendritic cell immune response
09/29/2005US20050216208 Diagnostic decision support system and method of diagnostic decision support
09/29/2005US20050216207 Artificial intelligence and global normalization methods for genotyping
09/29/2005US20050216202 Method for processing missing values in measured data
09/29/2005US20050215871 Accurate transcutaneous continuous biofluid monitoring systems; containing agent to catalyze degradation of reactive oxygen and/or nitrogen species near interface
09/29/2005US20050215775 70 human secreted proteins
09/29/2005US20050215766 Allergen from mugwort pollen
09/29/2005US20050215604 Combination therapies with epothilones and carboplatin
09/29/2005US20050215519 Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
09/29/2005US20050215505 Genetically engineered soluble form of CD39L3 or fusion protein of soluble form with heterologous sequence; deletions and replacements; anticoagulant, antiinflammatory, antihypoxic, and antiischemic agents; atherosclerosis, arteriosclerosis, preeclampsia, strokes; cardiovascular disorders
09/29/2005US20050215504 Antisense modulation of sterol regulatory element-binding protein-1 expression
09/29/2005US20050215502 Regulation of endogenous gene expression in cells using zinc finger proteins
09/29/2005US20050215500 aoaligonucleotides containing activated lymphocytes; antibody therapy; skin disorders; antiallergens
09/29/2005US20050215483 Peptide inhibitors of protein kinase c
09/29/2005US20050215479 Diagnostic indicator of thymic function
09/29/2005US20050214943 Transcription factors; nuclear localization peptides; signal sequences; NF-kappaB/Rel proteins; modulating expression of a gene
09/29/2005US20050214931 System and method for analyzing biochip
09/29/2005US20050214930 Device for cleanly separating array slide from gasket slide; enhancing accuracy of gene expression analysis
09/29/2005US20050214928 Single use device for characterizing and classifying blood cells
09/29/2005US20050214926 Adhering nucleotide sequences to solid support; gene expression analysis
09/29/2005US20050214918 Novel purified polypeptides from streptococcus pneumoniae
09/29/2005US20050214895 Methods for determining microbial contamination of allograft products
09/29/2005US20050214894 High throughput assay
09/29/2005US20050214893 Identifying modulators for prevention and treatment of cell proliferative disorders; antitumor agents
09/29/2005US20050214891 Using variation in enzyme-coenzyme complex as tool in monitoring blood glucose levels
09/29/2005US20050214890 Novel "Cleave-N-Read" system for protease activity assay and methods of use thereof
09/29/2005US20050214888 Using animal models to isentify modulators of cAMP responsive element binding protein (CREB) activity; for treatment and prevention of brain and cell proliferative disorders; antisense agents; antitumor agents
09/29/2005US20050214887 Method for analyzing residual agricultural chemical
09/29/2005US20050214885 Method for detecting mild impaired glucose tolerance or insulin hyposecretion
09/29/2005US20050214884 Method for stabilizing cholesterol dehydrogenase, cholesterol dehydrogenase-containing composition and cholesterol measuring reagent
09/29/2005US20050214883 Novel alanine transaminase enzyme and methods of use
09/29/2005US20050214880 Salivary soluble CD44: a molecular marker for head and neck cancer
09/29/2005US20050214879 Novel ubiquitin ligases as therapeutic targets
09/29/2005US20050214875 Metal chelate containing compositions for use in chemiluminescent assays
09/29/2005US20050214869 Molecular interactions in hematopoietic cells
09/29/2005US20050214868 Using receptor binding site as base module for dual specificity recognition molecule; drug screening and design
09/29/2005US20050214857 Method for displaying loops from immunoglobulin domains in different contexts
09/29/2005US20050214855 Non-specific binding resistant protein arrays and methods for making the same
09/29/2005US20050214854 Testing multiple fluid samples with multiple biopolymer arrays
09/29/2005US20050214853 Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
09/29/2005US20050214852 Peptides for the treatment and diagnosis of systemic lupus erythematosus
09/29/2005US20050214851 Linearized vector for heterologus gene transfer, control and expression
09/29/2005US20050214849 DNA sequencing method
09/29/2005US20050214848 Reagents and methods useful for detecting diseases of the breast
09/29/2005US20050214846 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/29/2005US20050214845 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
09/29/2005US20050214844 Nucleotide sequences coding translocation protein for use in identifying modulators for prevention and treatment of cell proliferative ,inflammatory and autoimmune disorders
09/29/2005US20050214843 Propargyl substituted nucleoside compounds and methods
09/29/2005US20050214842 Using probe visualization as tool in detecting chromosomal rearrangements in cells; colorimetic analysis; cancer diagnosis